Postbiotics vs. Fish Oil for Dog Inflammation: Which One Actually Helps More?

By Koranda Walsh, VMD, DACVIM (SAIM), DACVP (CP)

Comparisons · August 5, 2026 · 6 min read

Fish oil has proven canine osteoarthritis benefit through force-plate studies; postbiotics deliver gut-barrier evidence without equivalent joint-inflammation proof.

Here’s the call before the caveats: if I’m looking at bloodwork and a joint exam on an arthritic dog today, I’m reaching for fish oil first. Postbiotics get a slower nod — worth adding, not worth replacing anything with yet.

I read labels for a living, and I read bloodwork before I read marketing copy. That habit is why this comparison isn’t close, at least not yet. One category has decades of dosed, repeated, peer-reviewed trials showing measurable changes in lameness scores and inflammatory markers. The other has a lot of promising cell-culture and small-cohort data, an official definition from 2021, and not much long-term canine outcome evidence to stand on. Both can matter for a dog’s gut and joints. They are not interchangeable, and they are not equally proven.

What “postbiotic” actually means, and why that matters

The International Scientific Association for Probiotics and Prebiotics settled on a formal definition in 2021: a postbiotic is a preparation of inactivated microorganisms and/or their components that confers a health benefit on the host, a point walked through in detail in the National Center for Biotechnology Information: Frequently Asked Questions About the ISAPP Postbiotic Definition. That’s a meaningfully different product than a probiotic. Because the microbes are already inactivated, there’s no live culture to keep alive through shipping, storage, and a dog’s stomach acid — which is a real manufacturing and shelf-stability advantage, even before you get to the biology.

The biology itself is where things get interesting but incomplete. A 2025 systematic review and meta-analysis, PMC: Effects of Postbiotic Administration on Canine Health, pulled together the available canine trials and found real signal in specific contexts — postbiotics showed clinical improvement in dogs with atopic dermatitis, and mechanistic work points to short-chain fatty acid production, tighter gut-barrier junctions, and suppressed inflammatory pathways as the likely routes. But when the authors pooled outcomes across studies for a formal meta-analysis, several of those comparisons didn’t reach statistical significance against control groups. The sample sizes are small, the bacterial strains used vary widely between products, and study designs aren’t standardized enough yet to say “postbiotics reduce inflammation in dogs” as a blanket clinical statement. That’s not a knock on the mechanism — it’s an honest read of where the evidence currently sits.

Fish oil’s case: this is the trial data everyone else is chasing

Fish oil doesn’t have that problem. A randomized, double-blind, multicenter trial reported in the Journal of the American Veterinary Medical Association: Evaluation of the Effects of Dietary Supplementation With Fish Oil Omega-3 Fatty Acids on Weight Bearing in Dogs With Osteoarthritis, published in JAVMA, randomized 74 dogs with radiographically confirmed osteoarthritis to fish oil (at a 3 EPA ratio) or a mineral-oil placebo. The fish oil group showed objectively measured improvement in weight bearing on force plates — not owner impression, not a subjective lameness score alone, an actual force-plate number — and that improvement correlated with rising blood omega-3 levels. A separate multicenter practice assessment found comparable results feeding a food with a substantially increased omega-3 content and lowered omega-6-to-omega-3 ratio, with a significant change in peak vertical force in the test group versus essentially no change in controls.

That’s the difference in maturity between these two categories in one sentence: fish oil has multiple independent, randomized, objectively measured trials in dogs with confirmed joint disease. Postbiotics have a growing, genuinely promising body of work that hasn’t cleared that same bar yet.

In my practice, the dogs where this distinction actually shows up are usually mid-size, seven-plus, the kind of Lab or Lab mix that’s gone from bounding off the porch steps to hesitating at the top of them. I had a 9-year-old, 68-pound yellow Lab in for a senior bloodwork panel a few months back — owner mentioned, almost in passing, that he’d stopped jumping into the SUV around Christmas and was now taking the stairs one at a time instead of two. Inflammatory markers on the chemistry panel weren’t dramatic, but the gait told the real story: stiff for the first ten minutes after a nap, looser by the time he’d walked the block. We started fish oil at a therapeutic dose, dosed to his weight rather than a scoop-and-hope amount, and reassessed at six weeks. The owner was weighing cost against a joint supplement she’d already been giving him, and the honest answer was: keep both, but don’t expect the joint chew to do the job fish oil is built to do. That’s a single case, not a study — but it’s the pattern I see often enough that the trial data tracks with what’s in front of me at the exam table.

Reading the label: dose is where most owners lose the benefit

A fish oil bottle that doesn’t list combined EPA+DHA content in milligrams per capsule or per milliliter isn’t giving you enough to dose correctly — “fish oil” as a category term tells you nothing about strength. The published osteoarthritis trials used specific, weight-based EPA dosing, not a generic splash on the kibble. If a product’s label can’t answer “how many milligrams of EPA and DHA per serving, and per pound of my dog,” it’s not comparable to what got studied.

Postbiotic labels have their own reading problem right now: strain and process disclosure. Because the category covers everything from heat-killed Bifidobacterium to fermentation-derived metabolite blends, two products both marketed as “postbiotic” may not share a mechanism, let alone a dose-response relationship. Until the field standardizes strain and process reporting the way probiotic labeling has (slowly) started to, treat postbiotic claims as directionally promising rather than dosed and proven.

Where postbiotics genuinely earn a place on the shelf

None of this means skip postbiotics. The gut-barrier and atopic-dermatitis signal in the current research is real enough that I don’t dismiss it, and postbiotics pair logically with gut-focused strategies — this is closely related terrain to the prescription-versus-over-the-counter probiotic question I get asked about constantly, where label transparency is also the deciding factor. If a dog has diagnosed gut-barrier issues, skin flares tied to gut dysbiosis, or a vet-supported reason to target the microbiome specifically, postbiotics have a legitimate, evidence-backed rationale — just not yet the joint-inflammation trial base that fish oil has.

The dogs I see doing best long-term are usually on a layered plan, not a single supplement swapped for another. A 34-pound terrier mix I worked with — arthritic in both stifles, food-motivated to the point that pill-splitting was a nonstarter for the owner — ended up on a fish oil dose built around her actual weight, plus a postbiotic-containing gut-support product the owner already liked for stool consistency. Neither ingredient was asked to do the other’s job. That’s the sequencing I’d defend: fish oil for the joint and systemic inflammation question, postbiotics layered in for gut-specific goals, reassessed at six to eight weeks with an actual mobility check, not just “he seems better.”

The strongest counterargument, and why it doesn’t move the verdict

The fair pushback here is that fish oil trials, while real, are still a modest handful of studies — not a mountain of replication the way some human cardiovascular omega-3 research is. That’s true, and worth naming plainly rather than glossing over. But “a modest handful of randomized, objectively measured canine trials” still outweighs “promising mechanistic and small-cohort data without a significant pooled effect,” which is where the current postbiotic meta-analysis actually lands. If new large-scale canine postbiotic trials produce the same kind of force-plate or validated pain-score results the fish oil studies did, this verdict should move. It hasn’t yet.

Cold weather is one of the other variables owners ask me about in the same breath as supplements — whether a dog is actually stiffer in winter or whether that’s confirmation bias, which is its own question I’ve addressed in does cold weather really make a senior dog stiffer. Worth ruling out before assuming a supplement failed.

So: is your dog’s problem primarily inflamed, aching joints, or a gut that needs settling? That question probably decides more of this than any label does.